Candriam S.C.A. Schrodinger, Inc. Transaction History

Candriam S.C.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$24.74 - $35.13 $865,900 - $1.23 Million	35,000 Added 24.65%	177,000 $4.78 Million
Q4 2023 Feb 14, 2024	BUY	$21.62 - $37.21 $1.56 Million - $2.68 Million	72,000 Added 102.86%	142,000 $5.08 Million
Q3 2023 Nov 13, 2023	SELL	$27.34 - $55.37 $2.46 Million - $4.98 Million	-90,000 Reduced 56.25%	70,000 $1.98 Million
Q2 2023 Aug 08, 2023	SELL	$26.1 - $49.92 $783,000 - $1.5 Million	-30,000 Reduced 15.79%	160,000 $7.99 Million
Q1 2023 May 12, 2023	BUY	$18.09 - $27.61 $904,500 - $1.38 Million	50,000 Added 35.71%	190,000 $5 Million
Q4 2022 Feb 13, 2023	BUY	$16.24 - $26.38 $2.27 Million - $3.69 Million	140,000 New	140,000 $2.62 Million

236

60.5M

433K

381K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.16B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.